dihexa transdermal Dihexa: 10-50mg*10 vials - Nexus peptides dihexa studies Bond Peptides GLOW

This drug has an extremely low addiction and dependency potential, therefore classifying it as a Schedule IV drug here in Nashville

doi: 10.1093/ajcn/26.8.831

The FDA recently banned AOD 9604 from compounding due to safety concerns and lack of approval for medical use

Its very dangerous. Health Canada said that it continues to monitor the marketplace and encourages anyone with information about potential non-compliant or unauthorized health products to report it using the online complaint form. Health Canada also advises consumers to only purchase prescription drugs from licensed pharmacies and to verify that any health product has been authorized for sale in Canada.

All six doses are available: 2.5 mg ($299), 5 mg ($399), 7.5 mg ($499), 10 mg ($699), 12.5 mg ($699), and 15 mg ($699) per month